We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Download Mobile App




Near-Patient Sepsis Triage Test Provides Results in 20 Minutes

By HospiMedica International staff writers
Posted on 08 Jul 2022
Print article
Image: Symphony IL-6 test is intended for measuring IL-6 using whole blood (Photo courtesy of Bluejay Diagnostics)
Image: Symphony IL-6 test is intended for measuring IL-6 using whole blood (Photo courtesy of Bluejay Diagnostics)

Interleukin-6 (IL-6), an established biomarker of immune system activation, is elevated in infection, inflammation, and cancer, and presents as an early “first responder” that needs to be measured quickly and reliably. Now, a new test for sepsis triage that measures IL-6 is designed to provide accurate, reliable results in approximately 20 minutes from ‘sample-to-result’ and help medical professionals make earlier and better triage/treatment decisions.

Bluejay Diagnostics, Inc.’s (Acton, MA, USA) is developing the Symphony IL-6 Test to rapidly measure IL-6 in whole blood in a near-patient setting that is intended to help healthcare professionals make better treatment decisions for patients with life threatening diseases. The Symphony IL-6 Test is designed to run on Bluejay’s Symphony System that is intended to address the need for simple, reliable, rapid near-patient testing. The Symphony System is based on a well-accepted test method (ELISA, Enzyme-Linked Immunosorbent Assay) using advances in nanotechnology and new approaches to microfluidics.

The Symphony System is designed to provide quantitative measurements of specific biomarkers to determine the need for additional patient care and monitoring, when used in combination with other test and laboratory measurements. The system does not require any sample prep and has been shown in published clinical studies to deliver results in about 24 minutes. This user-friendly system is expected to fit into ICU/near-patient settings without the need for dedicated staff to run a test. The system has been designed to measure test analytes using whole blood. Samples are collected and loaded into proprietary, test-specific cartridges. Bluejay has completed the planned clinical studies for the Symphony IL-6 Test which is currently a development stage product candidate.

“Efficient measurement of clinically relevant biomarkers in critical care settings may help medical professionals make more timely and effective treatment decisions,” said Neil Dey, Chief Executive Officer of Bluejay Diagnostics, Inc. “With the progress made in our clinical program for the Symphony IL-6 Test, we are closer to executing our mission of providing first-in-class, near-patient, laboratory quality tests using whole blood.”

Related Links:
Bluejay Diagnostics, Inc. 

New
Gold Supplier
Creatinine Meter
StatSensor Xpress Creatinine Meter
New
Digital Video Colposcope
CS6/CS6 Pro
New
Blood Warmer
SAHARA-III 230 V
New
Capnograph/Pulse Oximeter
Handleld Capnograph/Pulse Oximeter

Print article

Channels

AI

view channel
Image: A novel research study moves the needle on predicting coronary artery disease (Photo courtesy of Pexels)

AI-Enabled ECG Analysis Predicts Heart Attack Risk Nearly as well as CT Scans

Increased coronary artery calcium is a marker of coronary artery disease that can lead to a heart attack. Traditionally, CT scans are used to diagnose buildup of coronary artery calcium, although CT scanners... Read more

Critical Care

view channel
Image: New spray fights infections and antibiotic resistance (Photo courtesy of Chalmers University of Technology)

Hydrogel-Based Spray Kills Antibiotic-Resistant Bacteria in Wounds and Biomedical Implants

Antibiotic resistance has been ranked among the top ten threats to global health by the World Health Organization (WHO). Antibiotic-resistant bacteria is estimated to cause almost 1.3 million deaths annually... Read more

Surgical Techniques

view channel
Image: The Inspira aspiration catheter has received CE Mark approval (Photo courtesy of Infinity Neuro)

Innovative Aspiration Catheter for Treatment of Stroke Delivers Next-Level Navigation Performance

Stroke is a disease that affects the arteries within and leading to the brain. Globally, stroke is the second-leading cause of death and the third-leading cause of death and disability combined.... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more

Business

view channel
Image: Researchers expect broader adoption of AI in healthcare in the near future (Photo courtesy of Pexels)

Artificial Intelligence (AI) Could Save U.S. Healthcare Industry USD 360 Billion Annually

The wider adoption of artificial intelligence (AI) in healthcare could save the U.S. up to USD 360 billion annually although its uptake in the industry is presently limited owing to the absence of trust... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.